Tunisia

Healthcare & Pharmaceutical Market Intelligence

North Africa's Balanced Pharmaceutical EcosystemQuality ManufacturingRegulatory Excellence

Quality Manufacturing • Regulatory Excellence • Regional Trade • Advanced Healthcare. GMP manufacturing, quality control laboratories and a gateway to North & Sub-Saharan Africa.

~12.3M

Population

USD 660M

Annual Imports

~60%

Local Production

USD 2.7B

Pharma Market

≈10–15%

Couples with Infertility

1. Strategic Advantages

Regulatory Maturity

✓Strong regulatory framework aligned with international standards
✓Skilled healthcare workforce with growing expertise
✓Modern infrastructure, advanced facilities & technology
✓Strategic regional position: gateway to North & Sub-Saharan Africa

2. Pharmaceutical Intelligence

Key Market Indicators

USD 2.7B

Market Size

~40% by value

Import Dependency

USD 100–180M

Nutraceutical Market • 6–9% CAGR

USD 45–95M

Fertility Market • 7–11% CAGR

Tunisia pharmaceutical distribution network

3. Import & Export Dynamics

USD 660M Imports • USD 130M Exports

Major Trade Partners

France
Germany
Italy
Spain
Türkiye

Strategic Supply Sources

Europe
India
China
North America

North Africa pharmaceutical trade network

4. Reproductive Health Intelligence

Advanced Clinical Fertility Ecosystem

12,000–15,000

IVF cycles per year

25–30

ART centers

35%

Male factor

28%

Female factor

8–13%

PCOS prevalence

Sources: Tunisia fertility market intelligence (mixed factor 30% • idiopathic 7% • infertility burden ≈10–15% of couples)

5. Women's Health Intelligence

Key Areas

Endometriosis

Fibroids

Metabolic disorders

Insulin resistance

Ovulatory disorders & PCOS

6. Why Tunisia Matters

Regulatory maturity

Quality manufacturing

Advanced healthcare

Regional trade connectivity

Sustainable growth